Steven Jon Russell

CIK: 0002051384

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (53.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (46.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BBNX

Beta Bionics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

BBNX
Beta Bionics, Inc.
Sep 2, 2026
Sale(S)
Direct
4.2K shares at avg. $19.11$81K
BBNX
Beta Bionics, Inc.
Jun 2, 2026
Sale(S)
Direct
4.2K shares at avg. $12.61$53K
BBNX
Beta Bionics, Inc.
Mar 2, 2026
Sale(S)
Direct
1K shares at avg. $12.36$13K
BBNX
Beta Bionics, Inc.
Feb 27, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
91.5K shares-
BBNX
Beta Bionics, Inc.
Feb 27, 2026
Award(A)
Direct
109.1K shares-
BBNX
Beta Bionics, Inc.
Dec 2, 2025
Sale(S)
Direct
1K shares at avg. $29.34$30K
BBNX
Beta Bionics, Inc.
Sep 2, 2025
Sale(S)
Direct
1K shares at avg. $18.86$19K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
94 shares at avg. $18.69$2K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
285 shares at avg. $17.03$5K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
660 shares at avg. $18.15$12K
BBNX
Beta Bionics, Inc.
Feb 27, 2025
Award(A)
Direct
35K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
53.6K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
81.2K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
90.6K shares-
BBNX
Beta Bionics, Inc.
Jan 29, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
90.6K shares-

		Type	Shares	Price		Ownership
Sep 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	4,221	$19.11	$80,676	Direct
Jun 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	4,222	$12.61	$53,227	Direct
Mar 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	1,026	$12.36	$12,683	Direct
Feb 27, 2026	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	91,520	-	-	Direct
Feb 27, 2026	BBNX Beta Bionics, Inc.	Award(A)	109,105	-	$0	Direct
Dec 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	1,025	$29.34	$30,069	Direct
Sep 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	1,015	$18.86	$19,146	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	94	$18.69	$1,757	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	285	$17.03	$4,853	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	660	$18.15	$11,978	Direct
Feb 27, 2025	BBNX Beta Bionics, Inc.	Award(A)	35,000	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	53,584	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	81,217	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	90,637	-	-	Direct
Jan 29, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	90,637	-	-	Direct

1-15 of 15 transactions

About Russell Steven Jon

Russell Steven Jon (SEC CIK 0002051384) files insider reports with the SEC as Chief Medical Officer of Beta Bionics, Inc. (BBNX).

Signal8 holds 11 ownership filings by Russell Steven Jon (1 Form 3, 10 Form 4), filed between Jan 29, 2025 and Sep 3, 2026. Those filings report 15 transactions, from Jan 29, 2025 to Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Russell Steven Jon's filings is in IRVINE, CA.

Recent filings by Russell Steven Jon

Sep 2, 2026: Open-market sale of BBNX shares (Form 4, code S).
Jun 2, 2026: Open-market sale of BBNX shares (Form 4, code S).
Mar 2, 2026: Open-market sale of BBNX shares (Form 4, code S).
Feb 27, 2026: Grants or awards of BBNX derivative securities (2 lines, Form 4, code A).
Dec 2, 2025: Open-market sale of BBNX shares (Form 4, code S).

Other insiders filing for Beta Bionics, Inc. (BBNX)

Mensinger Mike, Chief Product Officer
Hopman Mark, Chief Commercial Officer
Jones Christy, Director
Saint Sean, President & CEO
Feider Stephen, Chief Financial Officer
MICHEL GERARD J, Director

How to read Form 4 transaction codes